Comparison of Global, G-TL, & Cornell Media



Status:Withdrawn
Conditions:Women's Studies, Infertility
Therapuetic Areas:Reproductive
Healthy:No
Age Range:18 - 65
Updated:9/29/2018
Start Date:April 1, 2018
End Date:May 1, 2018

Use our guide to learn which trials are right for you!

A Randomized Controlled Trial Comparing Global Medium With G-TL, Cornell Single and Sequential Steps Media by the Time-Lapse System.

This is a prospective, randomized clinical trial to compare the Global commercial single step
media to 1) G-TL (Vitrolife), 2) Weill Cornell's single step and sequential steps media,
which all support human embryo development in the laboratory using the Vitrolife Time-Lapse
system. The main goal of the study is to identify the best culture medium for optimal embryo
development.

Culture media are used to culture embryos in order to support their development in the
laboratory. New media are being introduced to the market. Clinical studies have shown that
the use of the single-step Global medium for culture of human embryos from the zygote stage
to the blastocyst stage has resulted in better in-vitro development than a variety of
sequential media system.

Global is a FDA approved commercial single-step medium for all embryo culture from Day 0 to
the blastocyst stage.

G-TL (Time-Lapse) is a FDA approved commercial single-step medium from Vitrolife. It was
developed to be used with time-lapse devices as a continuous embryo culture medium from Day 0
to Day 5/6.

C3 is Cornell's in house made single-step buffered medium for embryo culture from oocyte
fertilization to blastocyst stage used as standard of care.

C1/C2 is Cornell's in house made buffered sequential medium otherwise known as multi step
medium, use to culture embryos for development. It is formulated to meet the embryos
requirements at two specific stages of development but require removal of the dish from the
incubator to physically exchange the culture media surrounding the embryos. This medium will
be the control.

Inclusion Criteria:

- 40 years of age or younger (maternal)

- 65 years of age or younger (paternal)

- 10 or more oocytes

- Fresh or frozen oocytes (including donor)

- Fresh or frozen (including donor) sperm can be used

- ICSI only

- Frozen embryos from this study can be included in the outcome portion of this study.

- PGD and/or PGS patients included

Exclusion Criteria:

- Patients with less than 10 oocytes

- Co-culture patients
We found this trial at
1
site
New York, New York 10065
?
mi
from
New York, NY
Click here to add this to my saved trials